# CCT-102 or Expectant Management in Delayed Pregnancy Loss

> **NCT06121063** · PHASE3 · COMPLETED · sponsor: **Conceptra Biosciences, LLC** · enrollment: 183 (actual)

## Conditions studied

- Early Pregnancy Loss, Delayed Pregnancy Loss

## Interventions

- **COMBINATION_PRODUCT:** CCT-102 A and CCT-102 B

## Key facts

- **NCT ID:** NCT06121063
- **Lead sponsor:** Conceptra Biosciences, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-21
- **Primary completion:** 2025-05-15
- **Final completion:** 2025-07-30
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06121063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06121063, "CCT-102 or Expectant Management in Delayed Pregnancy Loss". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06121063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*